Role of VDR gene polymorphisms with community acquired pneumonia in North Indian children: a case-control study

Nidhi Awasthi1, Shally Awasthi1, Shivani Pandey2

  • 1Department of Pediatrics, King George's Medical University Lucknow, UP, India.

Insights

The vitamin D receptor (VDR) gene

Area of Science:

  • Genetics and Molecular Biology
  • Pediatric Infectious Diseases
  • Nutritional Immunology

Background:

  • Community-acquired pneumonia (CAP) is a significant global child mortality cause.
  • The vitamin D receptor (VDR) gene influences inflammatory responses relevant to infection outcomes.
  • Investigating VDR gene polymorphisms may reveal insights into CAP susceptibility.

Purpose of the Study:

  • To examine the association between VDR gene polymorphisms (ApaI, FokI, TaqI, BsmI) and CAP in young children.
  • To identify specific VDR gene variants that may predispose children to CAP.

Main Methods:

  • A case-control study involving 160 hospitalized children with CAP and 160 age-matched healthy controls.
  • VDR gene polymorphisms (ApaI, FokI, TaqI, BsmI) were genotyped using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).
  • Exclusion criteria included cystic fibrosis and congenital heart disease.

Main Results:

  • The FokI (rs2228570) polymorphism showed a significant association with CAP risk.
  • Specifically, the heterozygous genotype (CT) [OR=2.06] and the mutant allele (T) [OR=1.45] of FokI were linked to an increased risk of CAP.
  • No significant associations were found for ApaI, TaqI, or BsmI polymorphisms with CAP.

Conclusions:

  • The FokI polymorphism in the VDR gene is associated with an increased risk of community-acquired pneumonia in Indian children.
  • These findings suggest that VDR gene variations could play a role in the pathogenesis of CAP in pediatric populations.
  • Further research is warranted to elucidate the precise mechanisms linking VDR FokI polymorphism to CAP susceptibility.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
305
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.5K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
451
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
463
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
802